Local News These Rare Human Neurons Generate Electrical Signals in Two Different Cellular Parts Allen Institute | September 17, 2021 It wasn’t an easy hunt. No fun scavenger clues on the way. This human brain…dcorriganSeptember 17, 2021 Read More
Local News Silverback Therapeutics Presents Interim Clinical Results from the Ongoing Phase I/Ib Study of SBT6050 Alone or In Combination with Pembrolizumab in Patients with Advanced or Metastatic HER2-Expressing Solid Tumors Silverback Therapeutics | September 17, 2021 Silverback Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop…dcorriganSeptember 17, 2021 Read More
Local News Can You Lose Weight? Ask Your Microbiome Institute for Systems Biology | September 15, 2021 The strongest associations with weight loss success or failure – independent of BMI – are…dcorriganSeptember 15, 2021 Read More
Local News RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels RareCyte | September 15, 2021 RareCyte, Inc., a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions,…dcorriganSeptember 15, 2021 Read More
Local News Seattle Startup Cyrus Inks Protein-Design Deal with Immune Biotech Selecta Worth Up to $1.5 Billion GeekWire | September 15, 2021 Seattle-based Cyrus Biotechnology is entering a protein engineering collaboration with Boston-based Selecta Biosciences that could…dcorriganSeptember 15, 2021 Read More
Local News Icosavax Initiates Phase I/Ib Trial of VLP Vaccine Candidate Against Respiratory Syncytial Virus Icosavax | September 13, 2021 Icosavax, Inc., a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop…dcorriganSeptember 13, 2021 Read More
Local News Neoleukin Therapeutics Announces Appointment of Bill Arthur, PhD, as Vice President and Head of Research Neoleukin Therapeutics | September 13, 2021 Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein…dcorriganSeptember 13, 2021 Read More
Local News Beyond Dopamine: New Reward Circuitry Discovered UW Medicine | September 10, 2021 The key to overcoming addictions and psychiatric disorders lives deep inside the netherworld of our…dcorriganSeptember 10, 2021 Read More
Local News University of Washington Spinout A-Alpha Bio Snags $20M for Protein-Discovery Platform GeekWire | September 10, 2021 A-Alpha Bio will build lab space in downtown Seattle and beef up its machine learning…dcorriganSeptember 10, 2021 Read More
Local News Common Virus That Besets Transplant Patients Is Study Focus UW Medicine | September 9, 2021 UW Medicine researchers will lead a $21 million, seven-year U.S. study of a novel vaccine’s…dcorriganSeptember 9, 2021 Read More